Annual Operating Profit
-$201.50 M
-$38.20 M-23.39%
31 December 2023
Summary:
Emergent BioSolutions annual operaing income is currently -$201.50 million, with the most recent change of -$38.20 million (-23.39%) on 31 December 2023. During the last 3 years, it has fallen by -$640.00 million (-145.95%). EBS annual operating profit is now -145.95% below its all-time high of $438.50 million, reached on 31 December 2020.EBS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$64.50 M
+$240.80 M+136.59%
30 September 2024
Summary:
Emergent BioSolutions quarterly operating income is currently $64.50 million, with the most recent change of +$240.80 million (+136.59%) on 30 September 2024. Over the past year, it has increased by +$88.40 million (+369.87%). EBS quarterly operating profit is now -79.05% below its all-time high of $307.90 million, reached on 31 December 2021.EBS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$115.80 M
+$88.40 M+43.29%
30 September 2024
Summary:
Emergent BioSolutions TTM operating income is currently -$115.80 million, with the most recent change of +$88.40 million (+43.29%) on 30 September 2024. Over the past year, it has increased by +$90.50 million (+43.87%). EBS TTM operating profit is now -121.23% below its all-time high of $545.50 million, reached on 31 March 2021.EBS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.4% | +369.9% | +43.9% |
| 3 y3 years | -145.9% | +285.9% | -134.3% |
| 5 y5 years | -324.4% | -8.8% | -342.8% |
EBS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -145.9% | at low | -79.0% | +136.6% | -130.2% | +63.1% |
| 5 y | 5 years | -145.9% | at low | -79.0% | +136.6% | -121.2% | +63.1% |
| alltime | all time | -145.9% | at low | -79.0% | +136.6% | -121.2% | +63.1% |
Emergent BioSolutions Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $64.50 M(-136.6%) | -$115.80 M(-43.3%) |
| June 2024 | - | -$176.30 M(-543.0%) | -$204.20 M(+1348.2%) |
| Mar 2024 | - | $39.80 M(-190.9%) | -$14.10 M(-93.0%) |
| Dec 2023 | -$201.50 M(+23.4%) | -$43.80 M(+83.3%) | -$201.50 M(-2.3%) |
| Sept 2023 | - | -$23.90 M(-273.2%) | -$206.30 M(-9.4%) |
| June 2023 | - | $13.80 M(-109.3%) | -$227.70 M(-27.4%) |
| Mar 2023 | - | -$147.60 M(+203.7%) | -$313.50 M(+96.6%) |
| Dec 2022 | -$163.30 M(-142.6%) | -$48.60 M(+7.3%) | -$159.50 M(-181.0%) |
| Sept 2022 | - | -$45.30 M(-37.1%) | $197.00 M(-5.1%) |
| June 2022 | - | -$72.00 M(-1225.0%) | $207.60 M(-29.4%) |
| Mar 2022 | - | $6.40 M(-97.9%) | $294.10 M(-23.2%) |
| Dec 2021 | $383.10 M(-12.6%) | $307.90 M(-987.3%) | $383.10 M(+13.3%) |
| Sept 2021 | - | -$34.70 M(-339.3%) | $338.00 M(-22.1%) |
| June 2021 | - | $14.50 M(-84.8%) | $434.00 M(-20.4%) |
| Mar 2021 | - | $95.40 M(-63.7%) | $545.50 M(+24.4%) |
| Dec 2020 | $438.50 M(+284.3%) | $262.80 M(+328.7%) | $438.50 M(+73.0%) |
| Sept 2020 | - | $61.30 M(-51.3%) | $253.40 M(-3.6%) |
| June 2020 | - | $126.00 M(-1186.2%) | $262.80 M(+102.5%) |
| Mar 2020 | - | -$11.60 M(-114.9%) | $129.80 M(+13.7%) |
| Dec 2019 | $114.10 M(+27.1%) | $77.70 M(+9.9%) | $114.20 M(+139.4%) |
| Sept 2019 | - | $70.70 M(-1110.0%) | $47.70 M(-2905.9%) |
| June 2019 | - | -$7.00 M(-74.3%) | -$1.70 M(-102.4%) |
| Mar 2019 | - | -$27.20 M(-342.9%) | $72.10 M(-19.7%) |
| Dec 2018 | $89.80 M(-27.8%) | $11.20 M(-47.4%) | $89.80 M(-31.8%) |
| Sept 2018 | - | $21.30 M(-68.1%) | $131.69 M(-16.7%) |
| June 2018 | - | $66.80 M(-803.2%) | $158.16 M(+58.3%) |
| Mar 2018 | - | -$9.50 M(-117.9%) | $99.89 M(-19.6%) |
| Dec 2017 | $124.30 M(+17.8%) | $53.09 M(+11.1%) | $124.30 M(+1.8%) |
| Sept 2017 | - | $47.77 M(+460.1%) | $122.11 M(+11.2%) |
| June 2017 | - | $8.53 M(-42.8%) | $109.82 M(+10.7%) |
| Mar 2017 | - | $14.91 M(-70.7%) | $99.25 M(-5.9%) |
| Dec 2016 | $105.50 M(-25.4%) | $50.91 M(+43.5%) | $105.50 M(-11.9%) |
| Sept 2016 | - | $35.48 M(-1837.4%) | $119.74 M(-18.8%) |
| June 2016 | - | -$2.04 M(-109.7%) | $147.42 M(-13.7%) |
| Mar 2016 | - | $21.16 M(-67.5%) | $170.91 M(+40.7%) |
| Dec 2015 | $141.51 M(+58.7%) | $65.15 M(+3.1%) | $121.45 M(-8.0%) |
| Sept 2015 | - | $63.16 M(+194.4%) | $132.05 M(+32.2%) |
| June 2015 | - | $21.45 M(-175.8%) | $99.93 M(+15.7%) |
| Mar 2015 | - | -$28.31 M(-137.4%) | $86.34 M(-3.2%) |
| Dec 2014 | $89.19 M(+108.4%) | $75.75 M(+144.1%) | $89.19 M(+142.8%) |
| Sept 2014 | - | $31.03 M(+294.7%) | $36.73 M(+54.0%) |
| June 2014 | - | $7.86 M(-130.9%) | $23.84 M(-22.3%) |
| Mar 2014 | - | -$25.46 M(-209.3%) | $30.69 M(-28.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $42.80 M(+8.2%) | $23.29 M(+28.4%) | $42.80 M(-1.7%) |
| Sept 2013 | - | $18.15 M(+23.3%) | $43.54 M(+23.7%) |
| June 2013 | - | $14.71 M(-210.2%) | $35.21 M(+20.8%) |
| Mar 2013 | - | -$13.35 M(-155.5%) | $29.16 M(-26.3%) |
| Dec 2012 | $39.57 M(+23.3%) | $24.04 M(+144.8%) | $39.57 M(-35.7%) |
| Sept 2012 | - | $9.82 M(+13.5%) | $61.52 M(+15.8%) |
| June 2012 | - | $8.65 M(-394.5%) | $53.11 M(-17.9%) |
| Mar 2012 | - | -$2.94 M(-106.4%) | $64.67 M(+101.5%) |
| Dec 2011 | $32.10 M(-56.4%) | $45.99 M(+3166.3%) | $32.10 M(+52.3%) |
| Sept 2011 | - | $1.41 M(-93.0%) | $21.07 M(-47.7%) |
| June 2011 | - | $20.21 M(-156.9%) | $40.27 M(+15.5%) |
| Mar 2011 | - | -$35.51 M(-201.6%) | $34.87 M(-52.6%) |
| Dec 2010 | $73.56 M(+83.2%) | $34.96 M(+69.7%) | $73.56 M(+72.2%) |
| Sept 2010 | - | $20.61 M(+39.1%) | $42.72 M(+135.2%) |
| June 2010 | - | $14.81 M(+366.0%) | $18.16 M(-30.3%) |
| Mar 2010 | - | $3.18 M(-23.0%) | $26.06 M(-35.1%) |
| Dec 2009 | $40.15 M(+34.2%) | $4.13 M(-204.4%) | $40.15 M(+8.9%) |
| Sept 2009 | - | -$3.95 M(-117.4%) | $36.88 M(-34.3%) |
| June 2009 | - | $22.71 M(+31.5%) | $56.17 M(+56.0%) |
| Mar 2009 | - | $17.27 M(+1921.8%) | $36.02 M(+20.4%) |
| Dec 2008 | $29.93 M(-9.6%) | $854.00 K(-94.4%) | $29.93 M(-58.6%) |
| Sept 2008 | - | $15.34 M(+499.6%) | $72.23 M(+17.8%) |
| June 2008 | - | $2.56 M(-77.1%) | $61.31 M(+22.4%) |
| Mar 2008 | - | $11.18 M(-74.1%) | $50.10 M(+51.4%) |
| Dec 2007 | $33.09 M(-14.1%) | $43.16 M(+876.0%) | $33.09 M(-2.2%) |
| Sept 2007 | - | $4.42 M(-151.1%) | $33.83 M(-14.6%) |
| June 2007 | - | -$8.66 M(+48.5%) | $39.61 M(-43.6%) |
| Mar 2007 | - | -$5.83 M(-113.3%) | $70.21 M(-28.3%) |
| Dec 2006 | $38.51 M(-19.6%) | $43.90 M(+330.5%) | $97.99 M(+548.7%) |
| Sept 2006 | - | $10.20 M(-53.5%) | $15.11 M(-55.4%) |
| June 2006 | - | $21.95 M(0.0%) | $33.87 M(-17.2%) |
| Mar 2006 | - | $21.95 M(-156.3%) | $40.89 M(-14.6%) |
| Dec 2005 | $47.91 M(+269.9%) | -$38.99 M(-234.6%) | $47.91 M(+28.7%) |
| Sept 2005 | - | $28.97 M(0.0%) | $37.23 M(+27.8%) |
| June 2005 | - | $28.97 M(0.0%) | $29.14 M(+38.5%) |
| Mar 2005 | - | $28.97 M(-158.3%) | $21.05 M(+62.5%) |
| Dec 2004 | $12.95 M(-76.8%) | -$49.67 M(-337.9%) | $12.95 M(-79.3%) |
| Sept 2004 | - | $20.87 M(0.0%) | $62.62 M(+50.0%) |
| June 2004 | - | $20.87 M(0.0%) | $41.75 M(+100.0%) |
| Mar 2004 | - | $20.87 M | $20.87 M |
| Dec 2003 | $55.77 M(+47.7%) | - | - |
| Dec 2002 | $37.77 M(-16.6%) | - | - |
| Dec 2001 | $45.31 M | - | - |
FAQ
- What is Emergent BioSolutions annual operaing income?
- What is the all time high annual operating profit for Emergent BioSolutions?
- What is Emergent BioSolutions annual operating profit year-on-year change?
- What is Emergent BioSolutions quarterly operating income?
- What is the all time high quarterly operating profit for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly operating profit year-on-year change?
- What is Emergent BioSolutions TTM operating income?
- What is the all time high TTM operating profit for Emergent BioSolutions?
- What is Emergent BioSolutions TTM operating profit year-on-year change?
What is Emergent BioSolutions annual operaing income?
The current annual operating profit of EBS is -$201.50 M
What is the all time high annual operating profit for Emergent BioSolutions?
Emergent BioSolutions all-time high annual operaing income is $438.50 M
What is Emergent BioSolutions annual operating profit year-on-year change?
Over the past year, EBS annual operaing income has changed by -$38.20 M (-23.39%)
What is Emergent BioSolutions quarterly operating income?
The current quarterly operating profit of EBS is $64.50 M
What is the all time high quarterly operating profit for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly operating income is $307.90 M
What is Emergent BioSolutions quarterly operating profit year-on-year change?
Over the past year, EBS quarterly operating income has changed by +$88.40 M (+369.87%)
What is Emergent BioSolutions TTM operating income?
The current TTM operating profit of EBS is -$115.80 M
What is the all time high TTM operating profit for Emergent BioSolutions?
Emergent BioSolutions all-time high TTM operating income is $545.50 M
What is Emergent BioSolutions TTM operating profit year-on-year change?
Over the past year, EBS TTM operating income has changed by +$90.50 M (+43.87%)